The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy
- 1 January 1982
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 10 (S1) , 157-168
- https://doi.org/10.1002/mpo.2950100715
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia.Published by Wiley ,1981
- A radioimmunoassay for cytosine arabinosideBritish Journal of Cancer, 1979
- Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.British Journal of Clinical Pharmacology, 1979
- Prevention and Treatment of Central Nervous System Leukaemia in ChildhoodPublished by Springer Nature ,1979
- Treatment of acute myeloid leukaemia with a triple cytotoxic regime: datBritish Journal of Cancer, 1977
- Pharmacokinetics of cytosine arabinoside in acute myeloid leukemiaClinical Pharmacology & Therapeutics, 1977
- Cytosine arabinoside as a single agent in the therapy of adult acute leukemiaThe Lancet Healthy Longevity, 1974
- Treatment of central nervous system leukemia with intrathecal cytosine arabinosideCancer, 1973
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Intrathecal arabinosyl cytosine in meningeal leukemiaCancer, 1970